RenovoRx Inc (RNXT) Q3 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
RenovoRx, Inc. (RNXT)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2025 revenue is $0.41 million, and the earnings are expected to come in at -$0.08 per share. The full year 2025's revenue is expected to be $1.26 million and the earnings are expected to be -$0.31 per share. More detailed estimate data can be found on the forecast page RenovoRx Inc ( NASDAQ:RNXT ) Estimates Trends Warning! GuruFocus has detected 1 Warning Sign with RNXT. Is RNXT fairly valued? Test your thesis with our free DCF calculator. Revenue estimates for RenovoRx Inc ( NASDAQ:RNXT ) have declined from $1.35 million to $1.26 million for the full year 2025 and declined from $5.43 million to $5.22 million for 2026 over the past 90 days. Earnings estimates have increased from -$0.33 per share to -$0.31 per share for the full year 2025 and increased from -$0.36 per share to -$0.34 per share for 2026 over the past 90 days. RenovoRx Inc ( NASDAQ:RNXT ) Reported History In the previous quarter of 2025-06-30, RenovoRx Inc's ( NASDAQ:RNXT ) actua
Show less
Read more
Impact Snapshot
Event Time:
RNXT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RNXT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RNXT alerts
High impacting RenovoRx, Inc. news events
Weekly update
A roundup of the hottest topics
RNXT
News
- RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9thGlobeNewswire
- RenovoRx (NASDAQ:RNXT) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- RenovoRx (NASDAQ:RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $12.00 to $12.50. They now have a "buy" rating on the stock.MarketBeat
- RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20thGlobeNewswire
- RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MDGlobeNewswire
RNXT
Earnings
- 5/15/25 - In-Line
RNXT
Sec Filings
- 11/24/25 - Form 4
- 11/14/25 - Form 8-K
- 11/14/25 - Form 424B5
- RNXT's page on the SEC website